Hernan A Bazan1, Samuel A Hatfield1, Aaron Brug1, Ashton J Brooks1, Daniel J Lightell1, T Cooper Woods2. 1. From the Section of Vascular and Endovascular Surgery, Department of Surgery, Ochsner Clinic, New Orleans, LA (H.A.B., A.J.B.); The University of Queensland School of Medicine, Ochsner Clinical School, New Orleans, LA (H.A.B., A.J.B.); and Department of Physiology and the Heart & Vascular Institute, Tulane School of Medicine, New Orleans, LA (S.A.H., A.B., A.J.B., D.L., T.C.W.). 2. From the Section of Vascular and Endovascular Surgery, Department of Surgery, Ochsner Clinic, New Orleans, LA (H.A.B., A.J.B.); The University of Queensland School of Medicine, Ochsner Clinical School, New Orleans, LA (H.A.B., A.J.B.); and Department of Physiology and the Heart & Vascular Institute, Tulane School of Medicine, New Orleans, LA (S.A.H., A.B., A.J.B., D.L., T.C.W.). Twoods3@tulane.edu.
Abstract
BACKGROUND: Atherosclerotic plaque rupture is accompanied by an acute decrease in the carotid plaque expression of micro-RNAs (miRs)-221 and miR-222. Circular RNA (circR)-284 is a potential inhibitor of miR-221/miR-222 activity. We aimed to determine whether changes in the serum levels of these noncoding RNAs are observed in patients with asymptomatic high-grade carotid disease versus patients with acutely symptomatic carotid disease and recent ischemic stroke. Additionally, we tested the use of functionally related noncoding RNA pairs to enhance the discriminatory power of noncoding RNAs as circulating biomarkers. METHODS AND RESULTS: Serum levels of miR-221, miR-222, miR-145, and circR-284 were measured in 24 asymptomatic (asymptomatic) and 17 acutely symptomatic patients ([urgent] ischemic cerebrovascular event within the previous 5 days) undergoing carotid endarterectomy. miR-221 was significantly lower, whereas circR-284 was elevated in the serum of the urgent compared with the asymptomatic group. The ratio of serum circR-284:miR-221 was significantly elevated in the urgent group (P=0.0002) and exhibited favorable characteristics as a biomarker indicative of carotid plaque rupture and stroke. A validation study in 112 patients (47 asymptomatic, 41 urgent, and 24 patients with a cerebrovascular event between 5 and 180 days of the carotid endarterectomy [symptomatic]) confirmed elevation of serum circR-284:miR-221 uniquely in the urgent group (P<0.001) and favorable sensitivity and specificity for detecting plaque rupture and stroke. CONCLUSIONS: Serum circR-284:miR-221 has potential as a diagnostic biomarker of carotid plaque rupture and stroke. Moreover, we demonstrate the use of functionally related pairs of circulating noncoding RNAs as biomarkers in cardiovascular disease.
BACKGROUND:Atherosclerotic plaque rupture is accompanied by an acute decrease in the carotid plaque expression of micro-RNAs (miRs)-221 and miR-222. Circular RNA (circR)-284 is a potential inhibitor of miR-221/miR-222 activity. We aimed to determine whether changes in the serum levels of these noncoding RNAs are observed in patients with asymptomatic high-grade carotid disease versus patients with acutely symptomatic carotid disease and recent ischemic stroke. Additionally, we tested the use of functionally related noncoding RNA pairs to enhance the discriminatory power of noncoding RNAs as circulating biomarkers. METHODS AND RESULTS: Serum levels of miR-221, miR-222, miR-145, and circR-284 were measured in 24 asymptomatic (asymptomatic) and 17 acutely symptomatic patients ([urgent] ischemic cerebrovascular event within the previous 5 days) undergoing carotid endarterectomy. miR-221 was significantly lower, whereas circR-284 was elevated in the serum of the urgent compared with the asymptomatic group. The ratio of serum circR-284:miR-221 was significantly elevated in the urgent group (P=0.0002) and exhibited favorable characteristics as a biomarker indicative of carotid plaque rupture and stroke. A validation study in 112 patients (47 asymptomatic, 41 urgent, and 24 patients with a cerebrovascular event between 5 and 180 days of the carotid endarterectomy [symptomatic]) confirmed elevation of serum circR-284:miR-221 uniquely in the urgent group (P<0.001) and favorable sensitivity and specificity for detecting plaque rupture and stroke. CONCLUSIONS: Serum circR-284:miR-221 has potential as a diagnostic biomarker of carotid plaque rupture and stroke. Moreover, we demonstrate the use of functionally related pairs of circulating noncoding RNAs as biomarkers in cardiovascular disease.
Authors: Eoin Clancy; Martina Burke; Vahid Arabkari; Thomas Barry; Helena Kelly; Róisín M Dwyer; Michael J Kerin; Terry J Smith Journal: Anal Bioanal Chem Date: 2017-03-27 Impact factor: 4.142
Authors: Hernan A Bazan; Samuel A Hatfield; Chasity B O'Malley; Ashton J Brooks; Daniel Lightell; T Cooper Woods Journal: Stroke Date: 2015-10-08 Impact factor: 7.914
Authors: Fabian Benz; Christoph Roderburg; David Vargas Cardenas; Mihael Vucur; Jérémie Gautheron; Alexander Koch; Henning Zimmermann; Jörn Janssen; Lukas Nieuwenhuijsen; Mark Luedde; Norbert Frey; Frank Tacke; Christian Trautwein; Tom Luedde Journal: Exp Mol Med Date: 2013-09-20 Impact factor: 8.718
Authors: Shujing Yuan; Jingnan Liang; Ming Zhang; Jiening Zhu; Rong Pan; Hui Li; Ni Zeng; Yihong Wen; Zhiyao Yi; Zhixin Shan Journal: Nan Fang Yi Ke Da Xue Xue Bao Date: 2019-11-30